Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
The purpose of this study is to assess the effects of a complex telemedicine intervention as a part of an integrated care program for patients with chronic obstructive pulmonary disease (COPD) discharged from the hospital after disease exacerbation. Will be evaluated whether the intervention produces benefits in terms of mortality, reduction in hospital readmissions and health-related quality of life. In addition, the trial evaluates the economical and organizational impact of the new service and examines its acceptability by patients and health professionals.
Interventions
PROCEDUREHome telehealth
Patients receive tailored intervention according to their clinical complexity. All patients in the intervention group receive: * Personalised care plan * Education on self-management * Access to a personalized online health folder * Access to Call center * Access to primary care and hospital specialists; follow-up visits for evaluation of clinical recovery and care plan adjustments (if needed). Patients with LOW complexity additionally receive: * Daily videoconferences for the 1st week after discharge * Remote monitoring for respiratory parameters. Sensors are selected on an individual basis by the medical specialists. Patients with HIGH complexity additionally receive: * Videoconferences for at least 1 month after discharge, scheduled on an individual basis. * Remote monitoring for respiratory parameters. * One monthly phone call from the call centre to promote and assess patient self-management.
Sponsors
Fundació TicSalut
Hospital Clinic of Barcelona
Hospital de Mataró
Catalan Agency for Health Information, Assessment and Quality
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Exacerbation of COPD * Age \> 40 years * Capability to use the devices provided * Willing to participate
Exclusion criteria
• Participation in a previous COPD home telehealth study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of hospital readmissions | 3 months period |
Secondary
| Measure | Time frame |
|---|---|
| Hospital anxiety and depression scale HADS | 3 months - at baseline and study end |
| Lung condition as measured by FEV1 | 3 months - at baseline and study end |
| Condition-related health status measured by COPD Assessment Test (CAT) | 3 months - at baseline and study end |
| Mortality | 3 months period |
| Health related quality of life of the patients as measured by the SF-36 v2 questionnaire | 3 months - at baseline and study end |
| Time in days to first readmission | 3 months period |
| Length of stay in days for each readmission | 3 months period |
| Number of emergency room visits | at the 3rd month (end of trial) |
| Patients' Acceptance-Satisfaction measured by the WSD Questionnaire | at the 3rd month of the telehealth intervention |
Countries
Spain
Outcome results
None listed